AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 170 filers reported holding AMAG PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 8.70 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $2,000 | 0.0% | 89 | 0.0% | 0.00% | 0.0% |
Q1 2019 | $2,000 | 0.0% | 89 | 0.0% | 0.00% | 0.0% |
Q4 2018 | $2,000 | 0.0% | 89 | 0.0% | 0.00% | +100.0% |
Q3 2018 | $2,000 | 0.0% | 89 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $2,000 | 0.0% | 89 | 0.0% | 0.00% | 0.0% |
Q1 2018 | $2,000 | +100.0% | 89 | 0.0% | 0.00% | – |
Q4 2017 | $1,000 | -50.0% | 89 | 0.0% | 0.00% | -100.0% |
Q3 2017 | $2,000 | 0.0% | 89 | 0.0% | 0.00% | 0.0% |
Q2 2017 | $2,000 | 0.0% | 89 | 0.0% | 0.00% | 0.0% |
Q1 2017 | $2,000 | -97.1% | 89 | -95.5% | 0.00% | -96.2% |
Q4 2016 | $70,000 | +11.1% | 1,999 | -21.8% | 0.03% | +13.0% |
Q3 2016 | $63,000 | +3.3% | 2,556 | 0.0% | 0.02% | -20.7% |
Q2 2016 | $61,000 | +1.7% | 2,556 | 0.0% | 0.03% | +11.5% |
Q1 2016 | $60,000 | -22.1% | 2,556 | 0.0% | 0.03% | -35.0% |
Q4 2015 | $77,000 | -24.5% | 2,556 | 0.0% | 0.04% | -31.0% |
Q3 2015 | $102,000 | -42.4% | 2,556 | 0.0% | 0.06% | -32.6% |
Q2 2015 | $177,000 | +26.4% | 2,556 | 0.0% | 0.09% | +8.9% |
Q1 2015 | $140,000 | – | 2,556 | – | 0.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Camber Capital Management LP | 4,390,000 | $33,584,000 | 1.92% |
Bleichroeder LP | 1,299,994 | $9,945,000 | 1.76% |
ARMISTICE CAPITAL, LLC | 4,120,000 | $31,518,000 | 1.38% |
Palo Alto Investors LP | 2,959,587 | $22,641,000 | 1.36% |
Permanens Capital L.P. | 359,461 | $2,750,000 | 1.04% |
IRONWOOD INVESTMENT MANAGEMENT LLC | 31,607 | $242,000 | 0.19% |
BOOTHBAY FUND MANAGEMENT, LLC | 348,000 | $2,662,000 | 0.18% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 795,611 | $6,086,000 | 0.07% |
Teza Capital Management LLC | 23,269 | $178,000 | 0.04% |
Livforsakringsbolaget Skandia, Omsesidigt | 38,800 | $297,000 | 0.03% |